Technology & Psychiatry

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.

The ATA published these principles “to ensure trustworthy development, integration, and utilization of AI in order to maximize its potential benefits as a meaningful tool for patients and providers.”

From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.

From deep brain stimulation for treatment-resistant schizophrenia to a look at the potential trajectory of artificial intelligence in psychiatry and medicine, here are highlights from the week in Psychiatric Times.

Here’s how placing current debates within historical context can help us better understand the potential trajectory of artificial intelligence in psychiatry and medicine.

According to research, 32% of patients said they did not typically receive care via their preferred method, and nearly half (45%) did not think their clinician considered their preferences when deciding on the visit type.

What is new in research on depression?

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

Here's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.

From the efficacy of adjunctive TMS for treatment-resistant major depression to a look at adult ADHD, here are highlights from the week in Psychiatric Times.

“This collaborative effort will help ensure that the application of health AI is based on the best science and is consistent with ethical principles and societal values in pursuit of effectiveness, efficiency, and equity for all members of society.”

The experts weighed in on a wide variety of psychiatric issues for the June 2023 issue of Psychiatric Times.

From an examination of the fentanyl epidemic to the connection between ADHD medication and height, here are highlights from the week in Psychiatric Times.

Does AI imagine itself as a replacement for psychiatry?

84% of 500 TikToks offered inaccurate or potentially damaging medical advice. How can you address TikTok as a mental health professional?

Experts discuss mental health with artificial intelligence.

"If we ignore or do not successfully address these future risks, we may need more than luck to avoid these looming disasters."

What happens when you talk to artificial intelligence?

How can we harness the technologies of today—and tomorrow—to expand access to mental health services?

From the cardiac adverse effects of lithium to the road to over-the-counter naloxone, here are highlights from the week in Psychiatric Times.

What is the buzz about the power of artificial intelligence?

How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?

What are the challenges and opportunities for improvement in COVID-19-related mental health care?

One psychiatrist considers the advantages of virtual psychiatric treatment for both patients and clinicians.

The American Foundation for Suicide Prevention collaborates with Most Days, a mental health app, to provide suicide prevention expertise and content. Learn more about the partnership here.

Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.

How can these mHealth apps help in the treatment of depression?

How can mHealth apps help overcome barriers to access to care?

Recent updates in suicide prevention interventions for older adults and how a novel tablet application may provide relief to individuals at high risk of suicide.